Jagath Reddy Junutula
President, Chief Executive Officer & Co- Founder Aarvik Therapeutics
Jagath Reddy is the Co‑founder, President, and CEO of Aarvik Therapeutics, where he leads the company’s vision to advance innovative oncology treatments through next‑generation therapeutic platforms. With more than a decade of leadership across emerging biotech, he has guided R&D strategy, clinical development, and company building as Senior Vice President of R&D and Chief Development Officer at AntlerA Therapeutics and as Co‑founder of multiple startups. Jagath also serves on the Boards of Aarvik Therapeutics and EPOK Therapeutics and previously contributed to NJ Bio’s Scientific Advisory Board, bringing deep expertise in drug discovery, translational development, and biotech innovation.
